Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
Abstract
The invention relates to compounds of formula (I) as well as their salts, having fungicidal activities: (CF DRAWING IN BOPI) in which the various radicals and substituents are as defined in the description, as well as the fungicidal compositions which contain them and methods of controlling phytopathogenic fungi in crops using these compounds and compositions.

Term
No projected expiry on record.
- Priority and filed
- Published
- Today
6 claims: 3 independent, 3 dependent
- 1-4Ί 2812633 -4Ί 2812633 Claims Revendications 1. Compounds of general formula (I) as well as their salts:1. Composés de formule générale (I) ainsi que leurs sels : dans laquelle • W représente O ou S ;in which • W represents O or S;• Y represents a radical -NRJrA -OR3 or -SR3 ;• Y représente un radical -NRJrA -OR3 ou -SR3 ;• R0 represents an alkyl, alkenyl, alkynyl, acyl, cyano, carbocyclyl or heterocyclyl radical, each of them possibly being substituted;or the hydrogen atom;or represents a single bond with Y;• RÛ représente un radical alkyle, alkényle, alkynyle, acyle, cyano, carbocyclyle ou hétérocyclyle, chacun d'entre eux pouvant être substitué ;ou l'atome d'hydrogène ;ou représente une liaison simple avec Y ;• R1 and R ^, which may be the same or different, represent any of the groups defined for R ^;or -NRatR ^, -ORat , -SRat , -S (O) Rat , -S (O)2Rat , in which Rat and R ^, which may be the same or different, represent an alkyl, alkenyl, alkynyl, acyl, cyano, sulfonyl, carbocyclyl or heterocyclyl radical, each of which may be substituted;or the hydrogen atom;• Rl et R^, qui peuvent être identiques ou différents, représentent l'un quelconque des groupes définis pour R^ ;ou -NRaR^ , -ORa , -SRa , -S(O)Ra , -S(O)2Ra , dans lesquels Ra et R^, qui peuvent être identiques ou différents, représentent un radical alkyle, alkényle, alkynyle, acyle, cyano, sulfonyle, carbocyclyle ou hétérocyclyle, chacun d'entre eux pouvant être substitué ;ou l'atome d'hydrogène ;• R3 represents any one of the groups defined for R0;• R3 représente l'un quelconque des groupes définis pour RÛ ;• Rl and R ^ or Rl and R® or R3 and RO or Rat and R ^, taken together with the atoms connecting them, can form a ring, optionally substituted, the whole then forming a carbocyclyl or heterocyclyl group;• Rl et R^ ou Rl et R® ou R3 et RO ou Ra et R^, pris ensemble avec les atomes les connectant, peuvent former un cycle, éventuellement substitué, l'ensemble formant alors un groupement carbocyclyle ou hétérocyclyle ;• R ^ represents an alkyl, alkenyl, alkynyl, carbocyclyl or heterocyclyl radical, each of them possibly being substituted;hydroxy;mercapto;azido;nitro;a halogen atom;cyano;acyl;optionally substituted amino;cyanato;thiocyanato;-SF5 ;-GOLDat ;-SRat or -If (Rat)3, in which Rat is as defined above;• R^ représente un radical alkyle, alkényle, alkynyle, carbocyclyle ou hétérocyclyle, chacun d'entre eux pouvant être substitué ;hydroxy ;mercapto ;azido ;nitro ;un atome d'halogène ;cyano ;acyle ;amino éventuellement substitué ;cyanato ;thiocyanato ;-SF5 ;-ORa ;-SRa ou -Si(Ra)3, dans lesquels Ra est tel que défini précédemment ;• m est un entier choisi parmi 0,1, 2 et 3 ;• m is an integer chosen from 0.1, 2 and 3;• R ^, when present, is the same or different from any of the other R3, and represents any one of the groups defined for R ^;• R^, lorsqu'il est présent, est identique ou différent de l'un quelconque des autres R3, et représente l'un quelconque des groupes définis pour R^ ;-48 2812633 • R.6 represents an optionally substituted carbo- or hetero-cyclyl radical;and • A represents a direct bond, -O-, -S (O) „-, -NR9-, -CR7= CR7-, -C = C-, -A1-, -A ^ Al-, -O- (Al) kO-, -O- (Al) k-, -A3-, -AT4-, -A ^ -, -AlS (O) n-, -A2-, -OA2-, -NR9AT2-, -OA2-Al-, -OA2-C (R7) = C (R8) -, -sîoxa1-, -AT1-AT4-, -48 2812633 • R.6 représente un radical carbo- ou hétéro-cyclyle éventuellement substitué ;et • A représente une liaison directe, -O-, -S(O)„-, -NR9-, -CR7=CR7-, -C=C-, -A1-, -A^Al-, -O-(Al)k-O-, -O-(Al)k-, -A3-, -A4-, -A^-, -AlS(O)n-, -A2-, -OA2-, -NR9A2-, -OA2-Al-, -OA2-C(R7)=C(R8)-, -sîoxa1-, -A1-A4-, -a]-a4-c(r8)=n-n=cr8-, -A^A^QR^N-X2^3-, -aU4-a3-, -at]-at4-c (r8) = nn = cr8-, -A ^ A ^ QR ^ NX2^3-, -at4-at3-, -A1-A4-N (R9)-, -To the4-X-CH2-, -a1-a4-a / -a! -A4-CH2X-, -A1-A4-N(R9)-, -Al-A4-X-CH2-, -a1-a4-a/ -a!-A4-CH2X-, -A1-A4-C(R8)=N-X2-X3-X1-, -A1-X-C(R8)=N-, -A1-X-C(R8)=N-N=CR8-, -A1-X-C(R8)=N-N(R9)-, -a!-X-A2-X1-, -Al-O-A3-, -A1-O-C(R7)=C(R8)-, -A1-O-N(R9)-A2-N(R9)-, -A^O-NiR9)^2-, -a1-N(R9)-A2-N(R9)-, -A1-N(R9)-A2-, -A1-N(R9)-N=C(R8)-, -a3-a1-, -a4-a3-, -A2-NR9-, -aW-X1-, -A^AÎ-A^X1-, -O-A2-N(R9)-A2-, -CR'^CR'^-X1-, -OC-A^X1-, -N=C(R8)-A2-Xl-, -C(R8)=N-N=C(R8)-, -C(R8)=N-N(R9)-, -(CH2)2-O-N=C(R8)ou-X-A2-N(R9)dans lesquels -AT1-AT4-C (R8) = NX2-X3-X1-, -AT1-XC (R8) = N-, -A1-XC (R8) = NN = CR8-, -AT1-XC (R8) = NN (R9) -, -a! -XA2-X1-, -Al-OA3-, -AT1-OC (R7) = C (R8)-, -AT1-WE R9)-AT2-N (R9) -, -A ^ O-NiR9)^2-, -a1-N (R9)-AT2-N (R9)-, -AT1-N (R9)-AT2-, -A1-N (R9) -N = C (R8)-, -at3-a1-, -a4-at3-, -AT2-NR9-, -aW-X1-, -A ^ AÎ-A ^ X1-, -OA2-N (R9)-AT2-, -CR '^ CR' ^ - X1-, -OC-A ^ X1-, -N = C (R8)-AT2-Xl-, -C (R8) = NN = C (R8) -, -C (R8) = NN (R9) -, - (CH2)2-ON = C (R8) or-XA2-N (R9)wherein - n represents 0, 1 or 2, - n représente 0, 1 ou 2, - k represents 1 to 9, - k représente 1 à 9, - Al represents -CHR7-, - Al représente -CHR7-, - A2 représente -C(=X)-, - AT2 represents -C (= X) -, - A3 représente -C(R8)=N-O-, - AT3 represents -C (R8) = NO-, - A4 représente -O-N=C(R8)-, - AT4 represents -ON = C (R8)-, - X represents O or S, - X représente O ou S, - χΐ represents O, S, NR9 or a direct link, - χΐ représente O, S, NR9 ou une liaison directe, - X2 represents O, NR9 or a direct link, - X2 représente O, NR9 ou une liaison directe, - X3 represents the hydrogen atom, -C (= O) -, -SO2- or a direct link, - X3 représente l'atome d’hydrogène, -C(=O)-, -SO2- ou une liaison directe, -R7 , qui peut être identique ou différent de l'un quelconque des autres R7, représente un radical alkyle, alkényle, alkynyle, cyano, acyle, hydroxy, alkoxy, haloalkoxy, alkylthio, cycloalkyle ou phényle, chacun d'entre eux pouvant être substitué ;ou représente l'atome d'hydrogène ou un atome d'halogène ;-R7 , which may be the same or different from any of the other R7represents an alkyl, alkenyl, alkynyl, cyano, acyl, hydroxy, alkoxy, haloalkoxy, alkylthio, cycloalkyl or phenyl radical, each of which may be substituted;or represents the hydrogen atom or a halogen atom;-R8 , qui peut être identique ou différent de l'un quelconque des autres R8, représente un radical alkyle, alkényle, alkynyle, alkoxy, alkylthio, carboou hétéro-cyclyle, chacun d'entre eux pouvant être substitué ;ou représente l'atome d'hydrogène ;-R8 , which may be the same or different from any of the other R8represents an alkyl, alkenyl, alkynyl, alkoxy, alkylthio, carbonor hetero-cyclyl radical, each of them possibly being substituted;or represents the hydrogen atom;-R9 , qui peut être identique ou différent de l'un quelconque des autres R9, représente un radical alkyle éventuellement substitué, un radical carbo-492812633 ou hétéro-cyclyle éventuellement substitué, l'atome d'hydrogène ou un radical acyle ;ou deux groupes R.9 dans A, pris ensemble avec les atomes les connectant, forment un cycle contenant de 5 à 7 chaînons ;-R9 , which may be the same or different from any of the other R9represents an optionally substituted alkyl radical, an optionally substituted carbo-492812633 or hetero-cyclyl radical, the hydrogen atom or an acyl radical;or two R.9 groups in A, taken together with the atoms connecting them, form a ring containing 5 to 7 members;- la partie droite des radicaux divalents -A- est reliée à r6 ;- the right part of the divalent radicals -A- is connected to r6;- -A-R6 et R5, pris ensemble avec le noyau benzénique M peuvent former un système cyclique fusionné éventuellement substitué. - -AR6 and R5, taken together with the benzene ring M can form an optionally substituted fused ring system.
- 3Compounds according to one of the preceding claims having the following characteristics taken individually or in combination:3. Composés selon l'une des revendications précédentes possédant les caractéristiques suivantes prises isolément ou en combinaison : • R ^ represents an alkyl radical in C, -C]0 or a halogen atom;• R^ représente un radical alkyle en C,-C]0 ou un atome d'halogènes ;• m represents l;• m représente l ;• RS represents a C | -C alkyl radical,o or a halogen atom, and preferably occupies position 5 on the M ring;• RS représente un radical alkyle en C|-C,o ou un atome d'halogènes, et occupe de préférence la position 5 sur le noyau M ;• A represents a direct bond or the divalent radical -O-, and occupies position 4 on the benzene ring M;• A représente une liaison directe ou le radical divalent -O-, et occupe la position 4 sur le noyau benzénique M ;• R6 represents a phenyl radical optionally substituted by one or more substituents which may be halogen, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, haloalkoxyalkyl, alkoxy, alkylthio, acyl or cyano. • R6 représente un radical phényle éventuellement substitué par un ou plusieurs substituants pouvant être halogènes, alkyle, alkényle, alkynyle, haloalkyle, alkoxyalkyle, hydroxyalkyle, haloalkoxyalkyle, alkoxy, alkylthio, acyle ou cyano.
- 4Use of the compounds according to any one of the preceding claims as fungicides. 4. Utilisation des composés selon l'une quelconque des revendications précédentes comme fongicides.
Independent claims3
626 paragraphs in 5 sections, as filed
J
Derivatives of phenyl (thio) ureas and phenyl (thio) carbamates fungicides
The present invention relates to novel derivatives of phenyl (thio) ureas and phenyl (thio) carbamates fungicides, their method of preparation and the fungicidal compositions which contain them.
[0002] Patent application WO 95/22532 describes phenyltriazolinones having a herbicidal activity. In particular, the compound of formula (A) is presented, for which no characteristic is given.
CF, CN (A)
The summary and the composition and use claims of this application refer only to the use of such compounds for herbicidal uses; the description indeed supports this description only with data of herbicidal activity. This application simply mentions a possible fungicidal activity for certain compounds. However, no fungicidal activity data is produced. There is no indication as to the nature of the compounds which may possess such fungicidal activity, and there is no disclosure as to the fungicidal activity of the compound (A).
The Applicant has now discovered that certain new carbamates, thiocarabamtes, ureas and thioureas, as well as their derivatives have fungicidal activity. Thus, the invention relates to the compounds of general formula (I) as well as their salts:
-22812633
<img file="FR2812633A1_D0001.tif" />
in which • W represents O or S;
• Y represents a radical -NR ^ R<sup>2</sup>, -OR ^ or -SR ^;
• R0 represents an alkyl, alkenyl, alkynyl, acyl, cyano, carbocyclyl or heterocyclyl radical, each of them possibly being substituted; or the hydrogen atom; or represents a single bond with Y;
• R<sup>1</sup> and R<sup>2</sup>, which may be the same or different, represent any of the groups defined for R ^; or -NR<sup>at</sup>R<sup>b</sup> , -GOLD<sup>at</sup>, -SR<sup>at</sup> , -S (O) R<sup>at</sup> , -S (O)<sub>2</sub>R<sup>at</sup>, in which R<sup>at</sup> and R<sup>b</sup>, which may be the same or different, represent an alkyl, alkenyl, alkynyl, acyl, cyano, sulfonyl, carbocyclyl or heterocyclyl radical, each of which may be substituted; or the hydrogen atom;
• R1 represents any one of the groups defined for R0;
• Rl and R<sup>2</sup> or Rl and R® or R ^ and RO or R<sup>at</sup> and R<sup>b</sup>, taken together with the atoms connecting them, can form a ring, optionally substituted, the whole then forming a carbocyclyl or heterocyclyl group;
• R<sup>4</sup> represents an alkyl, alkenyl, alkynyl, carbocyclyl or heterocyclyl radical, each of which may be substituted; hydroxy; mercapto; azido; nitro; a halogen atom; cyano; acyl; optionally substituted amino; cyanato; thiocyanato; -SF5; -GOLD<sup>at</sup> ; -SR<sup>at</sup> or -If (R<sup>at</sup>) 3, where R<sup>at</sup> is as defined above;
• m is an integer chosen from 0, 1, 2 and 3;
• R5, when present, is the same as or different from any of the other R ^, and represents any of the groups defined for R<sup>4</sup> ;
• Rb represents an optionally substituted carbo- or hetero-cyclyl radical;
-32812633 • A represents a direct bond, -O-, -S (O)<sub>not</sub>-, -NR<sup>9</sup>-, -CR<sup>7</sup>= CR<sup>7</sup>-, -OC-, -Al-, -Al-Al-, -O- (Al) kO-, -O- (Al) k-, -A3-, -A<sup>4</sup>-, -A ^ O-, -AlS (O) n-, -A2-, -Oa2-, -NR<sup>9</sup>AT<sup>2</sup>-, -0A2-A1-, -OA<sup>2</sup>-C (R<sup>7</sup>) = C (R<sup>8</sup>) -, -S ^ A<sup>1</sup>-, -A ^ A<sup>4</sup>-,
-A1-A<sup>4</sup>-C (R8) = NN = CR8-, -a1-A<sup>4</sup>-C (R<sup>8</sup>) = N-X2-x3-, _<sub>AT</sub>1-A<sup>4</sup>-a3-,
-a! -a<sup>4</sup>-n (r<sup>9</sup>) -, -a1-a<sup>4</sup>-x-ch2-, -a1-a<sup>4</sup>-a! -, -a<sup>1</sup>-at<sup>4</sup>-ch2x-, -Al-A<sup>4</sup>-C (R<sup>8</sup>) = N-X2-X3-xL -A<sup>1</sup>-XC (R<sup>8</sup>) = N-, -A<sup>1</sup>-XC (R<sup>8</sup>) = NN = CR<sup>8</sup>-, -A1-XC (R<sup>8</sup>) = NN (R<sup>9</sup>) -, -a! -X-a2-X1-, -aI-OA<sup>3</sup>-, -a! -OC (R<sup>7</sup>) = C (R<sup>8</sup>) -, -A1-ON (R<sup>9</sup>)-AT<sup>2</sup>-N (R<sup>9</sup>) -, -a! -ON (R<sup>9</sup>)-AT<sup>2</sup>-, -a! -N (R<sup>9</sup>)-AT<sup>2</sup>-N (R<sup>9</sup>) -, io -A1-N (R<sup>9</sup>) -a2-, -Al-N (R<sup>9</sup>) -N = C (R<sup>8</sup>) -, -a3-a1-, -A<sup>4</sup>-AT<sup>3</sup>-, -AT<sup>2</sup>-NR<sup>9</sup>-, -Αΐ-Α<sup>2</sup>-χ1-, -A1-a1-A<sup>2</sup>-X1-, -OA<sup>2</sup>-N (R<sup>9</sup>)-AT<sup>2</sup>-, -CR<sup>7</sup>= CR<sup>7</sup>-AT<sup>2</sup>-Xl-, -OC-A<sup>2</sup>-Xl-, -N = C (R<sup>8</sup>)-AT<sup>2</sup>-x1-, -C (R<sup>8</sup>) = NN = C (R<sup>8</sup>) -, -C (R<sup>8</sup>) = NN (R<sup>9</sup>) -, - (CH<sub>2</sub>)<sub>2</sub>-ON = C (R<sup>8</sup>) or-XA<sup>2</sup>-N (R<sup>9</sup>)wherein
- n represents 0, 1 or 2,
- k represents 1 to 9,
- Al represents -CHR<sup>7</sup>-,
- a2 represents -C (= X) -,
- A3 represents -C (R<sup>8</sup>) = NO-,
- AT<sup>4</sup> represents -ON = C (R<sup>8</sup>)-,
- X represents O or S,
- χΐ represents O, S, NR<sup>9</sup> or a direct link,
- χ2 represents O, NR<sup>9</sup> or a direct link,
- χ3 represents the hydrogen atom, -C (= O) -, -SO<sub>2</sub>- or a direct link,
-R<sup>7</sup> , which may be the same or different from any of the other R<sup>7</sup>represents an alkyl, alkenyl, alkynyl, cyano, acyl, hydroxy, alkoxy, haloalkoxy, alkylthio, cycloalkyl or phenyl radical, each of which may be substituted; or represents the hydrogen atom or a halogen atom;
-R<sup>8</sup> , which may be the same or different from any of the other R<sup>8</sup>represents an alkyl, alkenyl, alkynyl, alkoxy, alkylthio, carbonor hetero-cyclyl radical, each of them possibly being substituted; or represents the hydrogen atom;
R<sup>9</sup> , which may be the same or different from any of the others
R<sup>9</sup>, represents an optionally substituted alkyl radical, an optionally substituted carbonor hetero-cyclyl radical, the hydrogen atom or a radical
-42812633 acyl; or two groups in A, taken together with the atoms connecting them, form a ring containing 5 to 7 members;
- the right part of the divalent radicals -A- is connected to R ^;
- -AR<sup>6</sup> and R<sup>5</sup>, taken together with the benzene ring M can form an optionally substituted fused ring system.
According to a preferred aspect, the invention relates to the compounds of general formula (I) and the salts thereof in which:
• RO represents an alkyl, acyl or cyano radical, each of them possibly being substituted by alkoxy, haloalkoxy, alkylthio, halogen atom or phenyl optionally substituted by alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio or halogen atom ; or represents the hydrogen atom;
• Rl 'R ^ and R ^ are as defined above;
• R ^ represents an alkyl, alkenyl, alkynyl, alkoxy or alkylthio radical, each of them possibly being substituted by alkoxy, haloalkoxy, alkylthio, halogen atom or phenyl optionally substituted by alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio or halogen atom; or represents hydroxy; halogen atom; cyano; acyl (preferably -C (-O) R<sup>VS</sup>, -C (-S) R<sup>VS</sup> or -S (O) pR<sup>vs</sup>, in which p represents 0, 1 or 2 and R<sup>vs</sup> represents alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, amino, monoalkylamino, dialkylamino or phenyl optionally substituted by alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; or phenyloxy, phenylthio, carbocyclyl or heterocyclyl);
• m represents 0 or 1;
• when it is present, R5 represents a group defined for R ^ according to this characteristic;
• A represents a direct bond, or the divalent radicals -O-, -S-, -NR ^ -, -CHR? -, or -O-CHR? -, in which R ^ represents alkyl, alkenyl, or alkynyl, each of them possibly being substituted by alkoxy, haloalkoxy, alkylthio, halogen atom or phenyl optionally substituted by alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, or halogen atom; or represents the hydrogen atom; and R? represents a group defined for R ^ according to this characteristic or represents hydroxy, halogen atom, cyano, acyl, alkoxy, haloalkoxy or alkylthio; and • R<sup>6</sup> represents an aromatic phenyl or heterocyclyl radical (preferably thiazolyl, isothiazolyl, thiadiazolyl, pyridyl or pyrimidinyl), optionally substituted by one or more substituents, which may be identical or different, and are chosen from hydroxy, halogen atom, cyano, acyl (preferably
-52812633
-C (= O) R<sup>VS</sup>, -C (= S) R<sup>VS</sup> or -S (O) pR<sup>vs</sup>, in which p represents O, 1 or 2 and R<sup>vs </sup>represents alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, amino, monoalkylamino, dialkylamino or phenyl optionally substituted by alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; or phenyloxy, phenylthio, carbocyclyl or heterocyclyl), amino, alkylamino, dialkylamino, alkyl, alkenyl, alkynyl, haloalkyl, RaO-alkyl, acyloxyalkyl, cyano-oxyalkyl, alkoxy, haloalkoxy, alkylthio, carbocyclyl or cyclopentyl (preferably cyclohex) optionally by alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio; and benzyl optionally substituted by alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio;
[0005] According to a particularly preferred aspect of the invention, the latter relates to the compounds of general formula (I), and their salts, as defined above, and having the following characteristics taken alone or in combination:
• R ^ represents an alkyl radical in C, -C<sub>10</sub> or a halogen atom; îs · m represents 1;
• r5 represents an alkyl radical in C, -C<sub>I0</sub> or a halogen atom, and preferably occupies position 5 on the M ring;
• A represents a direct bond or the divalent radical -O-, and occupies position 4 on the benzene ring M;
· R ^ represents a phenyl radical optionally substituted by one or more substituents which may be halogen, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, hydroxyalkyl, haloalkoxyalkyl, alkoxy, alkylthio, acyl or cyano.
[0006] Complexes of the compounds according to the invention can be formed in the usual manner from a salt of formula NAn or NAn<sub>2</sub>, wherein N represents a metal cation, for example copper, manganese, cobalt, nickel, iron or zinc and An represents an anion, for example chloride, nitrate or sulfate.
[0007] The N-oxides of the compounds of the invention, when these comprise a nitrogen atom which can be oxidized, are also included in the scope of the present invention.
In cases where the compounds according to the invention exist in the form of geometric isomers E and Z, the invention comprises the individual isomers as well as mixtures thereof in all proportions.
-62812633
In cases where the compounds according to the invention exist in the form of tautomeric isomers, the invention comprises the individual tautomeric isomers as well as mixtures thereof in all proportions.
In cases where the compounds according to the invention exist in the form of optical isomers, the invention comprises the individual isomers as well as the mixtures thereof in all proportions, including the 50:50 mixture, said mixture racemic.
Any alkyl group defined above can be linear or branched and generally comprises from 1 to 10 carbon atoms, preferably from 1 to 7 carbon atoms, more preferably from 1 to 5 carbon atoms.
All the alkenyl or alkynl groups defined above can be linear or branched, preferably comprise from 2 to 7 carbon atoms, and generally contain up to 3 double or triple bonds which can be conjugated, for example vinyl, allyl, butadienyl or propargyl.
The carbocyclyl groups can be saturated, unsaturated or aromatic and contain from 3 to 8 members. Preferred saturated carbocyclyl groups include cyclopropyl, cyclopentyl, and cyclohexyl. Preferred unsaturated carbocyclyl groups have up to 3 double bonds. A preferred aromatic and phenyl carbocyclyl group. The term carbocyclic has the same definition in the present invention. In addition, the term carbocyclyl includes any type of fused carbocyclyl groups, such as naphthyl, phenanthryl, indanyl and indenyl.
The heterocyclyl groups can be saturated, unsaturated or aromatic and contain from 3 to 7 chains, among which up to 4 of them can be heteroatoms such as nitrogen, oxygen and sulfur. Thus, the term “heterocyclyl group” is understood to mean, for example, furyl, thienyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, imidazolyl, dioxolanyl, oxazolyl, thiazolyl, imidazolinyl, imidazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, isoxazoliazoliazoliazadanyl, isoxazoliazanyl, isoxazoliazanyl, isoxazoliazanyl, isoxazoliazadanyl, isoxazoliazadanyl, isoxazoliazadanyl, isoxazoliazanyl, isoxazoliazolyl, imidazolinyl, imidazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, isoxazoliazanyl, isoxazoliazadanyl, pyridyl, piperidinyl, dioxanyl, morpholino, dithianyl, thiomorpholino, pyridazinyl, pirimidinyl, pyrazinyl, piperazinyl, sulfolanyl, tetrazolyl, triazinyl, azepinyl, oxazepinyl, thiazepinyl, diazepinyl and thiazolinyl.
In addition, the term heterocyclyl includes fused heterocyclyl groups, for example, benzimidazolyl, benzoxazolyl, imidazopyridinyl, benzoxazinyl, benzothiazinyl, oxazolopyridinyl, benzofuranyl, benzolinyl, quinazoliniazinyl, qionazoliniazinyl, benzolinaziniazinyl, benzolinaziniazinyl, benzolinaziniazine indolyl and isoindolyl The term heterocyclic has the same definitions.
The substituted adjective qualifying the alkyl, alkenyl, alkynyl, carbocyclyl and heterocyclyl groups means that these groups can be substituted by one or more substituents, identical or different, chosen from: hydroxy, alkenyl, alkynyl, mercapto, azido, nitro, halogens, cyano, acyl, alkoxycarbonyl, optionally substituted aminocarbonyl, optionally substituted amino, optionally substituted ammonio, optionally substituted carbocyclyl, optionally substituted heterocyclyl, cyanato, thiocyanato, -SF5; -GOLD<sup>at</sup>; -SR<sup>at</sup>; -SOR<sup>at</sup>; -SÛ2R<sup>at</sup> and -Si (R<sup>at</sup>) 3, with R<sup>at</sup> being alkyl, alkenyl, alkynyl, carbocyclyl or heterocyclyl, each of them possibly being substituted. For the carbocyclyl and heterocyclyl groups, the list further comprises alkyl, alkenyl and alkynyl, each of them possibly being optionally substituted. Preferred substituents for the alkyl, alkenyl or alkynyl radicals are: alkoxy, haloalkoxy or alkylthio, each of which contains from 1 to 5 carbon atoms; halogen; or optionally substituted phenyl. Preferred substituents for the carbocyclyl and heterocyclyl groups are: alkyl, haloalkyl, alkoxy, haloalkoxy or alkylthio, each of which contains from 1 to 5 carbon atoms; halogen; or optionally substituted phenyl.
For the alkyl radicals and the carbon atoms of the carbocyclyl and heterocyclyl groups, the list includes divalent radicals such as oxo or imino, optionally substituted by optionally substituted amino, R<sup>at</sup> or -OR<sup>at </sup>(where R<sup>at</sup> is as defined above). Preferred radicals are oxo, imino, alkylimino, oximino, alkyloximino or hydrazono.
The amino groups, when they are substituted and where appropriate, can be substituted by one or two identical or different substituents, chosen from: alkyl, alkenyl, optionally substituted alkynyl, optionally substituted amino, -OR<sup>at</sup> (where R<sup>at</sup> is as defined above), carbocyclyl, heterocyclyl and acyl. According to another aspect, two substituents, with the nitrogen atom to which they are linked,
-82812633 may form a heterocyclyl group, preferably a 5 to 7 membered heterocyclyl group, which may be substituted and which may contain other heteroatoms, for example morpholino, thiomorpholino or piperidinyl.
The term acyl includes residues of sulfur and phosphorus acids and also carboxylic acids. Said residues are thus included in the general formulas: -C (= X<sup>at</sup>) R ^, -S (O) pR ^ and -P (= X<sup>at</sup>)(GOLD<sup>at</sup>)(GOLD<sup>at</sup>), where, appropriately, X<sup>at</sup> represents O or S, R ^ is as defined for R<sup>at</sup>, -GOLD<sup>at</sup>, -SR<sup>at</sup>, optionally substituted amino or acyl; and p represents 1 or 2. Preferred groups are -C (= O) R<sup>VS</sup>, -C (= S) R<sup>VS</sup>, and -S (O) pR<sup>vs</sup> in which R<sup>vs</sup> represents alkyl, C1-C5 alkoxy, C1-C5 alkylthio, phenyl, phenyloxy, phenylthio, carbocyclyl, heterocyclyl or amino, each of them possibly being optionally substituted.
The compounds according to the invention are useful as fungicides and control pathogens of the Deuteromycetes, Oomycetes, Ascomycetes, Phycomycetes and Basidiomycetes families. An antifungal activity is demonstrated on cereal diseases such as, for example:
• SEPTORIOSES of wheat (Leptosphaeria nodorum & Septoria tritici), • POWDERS (Erysiphe graminis f.sp hordei and Erysiphe graminis f.sp tritici), • RUST of wheat (Puccinia recondita, Puccinia striiformis), • PIETIN-VERSE wheat (Pseudocercosporella herpotrichoides), • HELMINTHOSPORIOSIS of barley (Drechslera ter es) and • RHYNCHOSPORIOSIS of barley (Rhynchosporiosis secalis).
Likewise:
• MILDIOUS of nightshades (Phytophthora infestons) and of vines (Plasmopara viticola), • GRAY ROT (Botrytis cinerea), • diseases of rice (PYRICULARIOSIS, PELLICULARIOSIS,
RHIZOCTONE) are controlled.
Thus the present invention also provides a method for combating phytopathogenic fungi in a place which is infested or liable to be so, which comprises the application in this place of a compound of formula (I) or of one of its salts.
-92812633
[0022] The invention also provides a composition for agriculture comprising a compound of formula (I) or one of its salts in admixture with an agriculturally acceptable diluent or carrier.
The composition according to the invention can of course comprise more than one compound according to the invention.
In addition, the composition may comprise one or more additional active ingredients, for example compounds known to have plant growth regulator properties, herbicidal, fungicidal, insecticidal, acaricidal, antimicrobial or antibacterial properties. The compound according to the invention can thus be used, for example, simultaneously, sequentially or alternatively with the other active material (s).
The diluent or the support in the composition according to the invention can be a solid or a liquid in combination with a surfactant, for example a dispersing agent, an emulsifying agent or a wetting agent. Suitable surfactants include anionic compounds such as a carboxylate, for example a metal carboxylate of a long chain fatty acid; a
A-acylsarcosinate; mono- or di-esters of phosphoric acid with fatty alcohol ethoxides or alkyl phenol ethoxides or salts of such esters; fatty alcohol sulfates such as sodium dodecyl sulfate, sodium octadecyl sulfate or sodium cetyl sulfate; ethoxylated fatty alcohol sulfates; ethoxylated alkyl phenol sulfates; lignin sulfonates; petroleum sulfonates; alkyl aryl sulfonates such as alkyl benzene sulfonates or lower alkyl naphthalene sulfonates, for example butyl naphthalene sulfonate; condensates of naphthalene sulfone-formaldehyde salts; condensates of sulfone-formaldehyde phenol salts; or more complex sulfonates such as amide sulfonates, for example the condensation product of oleic acid and sulfonated TV-methyl taurine; dialkyl-sulfosuccinates, for example sodium dioctyl-succinate sulfonate; acid derivatives of alkylglycoside and alkylpolyglycoside compounds and their metal salts, for example alkylpolyglycoside citrate or tartrate; or mono-, di- and tri-alkyl esters of citric acid and their metal salts.
- 102812633
[0026] Nonionic agents include condensation products of fatty acid esters, fatty alcohols, fatty acid amides or phenols substituted by fatty alkyl- or alkenyl-fatty acids with d-oxide. ethylene and / or propylene; fatty esters of polyhydric alcohol ethers, for example sorbitan esters of fatty acids; condensation products of such esters with ethylene oxide, for example polyoxyethylene sorbitan esters of fatty acids; alkyl glycoside products, alkyl polyglycoside products; block copolymers of ethylene oxide and propylene oxide; acetylenic glycols such as 2,4,7,9-tetramethyl-5-decyneio 4,7-diol; ethoxylated acetylenic glycols; acrylic link graft copolymers; alkoxylated siloxane surfactants; or imidazoline-type surfactants, for example 1-hydroxyethyl-2-alkylimidazoline.
Examples of cationic surfactants include, for example, a mono-, di- or polyamine, in the form of acetate, naphthenate or oleate; an oxygen-containing amine, such as an amine oxide, a polyoxyethylene-alkylamine or a polyoxypropylene-alkylamine; an amide linked to an amide prepared by condensation of a carboxylic acid with a di- or a polyamine; or a quaternary ammonium salt.
The compositions according to the invention can take any form in the field of the formulation of agrochemical compounds, for example, solution, aerosol, dispersion, aqueous emulsion, microemulsion, dispersible concentrate, powder to be sprayed, composition for coating or film-coating seeds, composition for fumigation or for smoking, dispersible powder, emulsifiable concentrate, granules or impregnated strip. In addition, they may be in a form suitable for direct application or as a concentrate or primary composition requiring dilution with a suitable amount of water or other diluent before application.
A dispersible concentrate comprises a compound according to the invention, dissolved in one or more solvents soluble in whole or in part in water, and one or more surfactants and / or polymers. The addition of the formulation in water causes crystallization of the active material, the process being controlled by surfactants and / or polymers, which results in a fine dispersion.
A pulverizable powder comprises a compound according to the invention mixed and thoroughly ground with a pulverulent solid diluent, for example, kaolin.
An emulsifiable concentrate comprises a compound according to the invention dissolved in a solvent immiscible with water and which forms an emulsion or a microemulsion upon addition in water in the presence of an emulsifying agent.
A solid granule comprises a compound according to the invention associated with diluents Io similar to those which can be used for sprayable powders, the mixture being here granulated according to known methods. According to one alternative, the solid granule comprises the active material absorbed or coated on a preformed granulated support, for example, Fuller's earth, attapulgite, silica or calcareous sand (limestone grit in English).
[0033] Wettable powders, granules or granules, usually comprise the active material in admixture with suitable surfactants and an inert powder diluent such as clay or diatomaceous earth.
Another suitable concentrate is a pourable concentrate suspension formed by grinding the compound with water or other liquid, surfactants and a suspending agent.
The concentration of the active material in the composition of the present invention, as applied to plants, is preferably between 0.0001 and 1.0 percent by weight, particularly between 0.0001 and 0.01 percent by weight. In a primary composition, the amount of active material can vary widely and can, for example, be between 5 and 95 percent by weight of the composition.
When used, a compound of the invention is generally applied to seeds, plants or their habitat. Thus, the compound can be applied directly to the soil before, at the time or after seeding so that the presence of the active material in the soil can control the growth of fungi which can attack the seeds. During a direct treatment of the soil, the active material can be applied in any way that allows it to be intimately mixed with the soil such as by spraying, by diffusion of granules in solid form or by application of the active material. at the same time
I! ''
- 122812633 than the seed by using it in the same planter as the seeds. A suitable application rate is between 5 and 1000 g per hectare, more preferably between 10 and 500 g per hectare.
(0037] Alternatively, the active material can be applied directly to the plant, for example by spraying or dusting either when the fungus has started to appear on the plant or before the appearance of the fungus as a protective measure. two cases the preferred mode of application is a spray on the leaves. It is generally important to achieve effective fungus control in the early stages of plant growth, since this is the time when the plant can be most severely damaged. The spray or dusting may conveniently contain a pre- or post-emergence herbicide if required, however. Sometimes it is feasible to treat the roots, bulbs, tubers or other vegetal growths of a plant before or during planting, for example, by soaking the roots in a suitable liquid or solid composition. When the active material is applied directly to the plant, a suitable application rate is between 0.025 and 5 kg per hectare, preferably between 0.05 and 1 kg per hectare.
In addition, the compounds according to the invention can be applied to fruits, vegetables or seeds harvested to prevent infection during storage.
(0039] In addition, the compounds according to the invention can be applied to plants or parts thereof which have been genetically modified.
In addition, the compounds according to the invention can be used to treat fungal infections in construction timber and for application to public health. The compounds according to the invention can also be used to treat fungal infections in domestic or farm animals.
Compounds according to the invention can be prepared by numerous routes, according to known methods.
(0042] Thus, the compounds of general formula (I) can for example be prepared from compounds of general formula (II) according to Scheme 1 below:
-13 2812633
Diagram 1
<img file="FR2812633A1_D0002.tif" />
<img file="FR2812633A1_D0003.tif" />
The following reaction conditions can be used to carry out the conversion of compounds of formula (II) into compounds of formula (I):
• generally reaction with C1 (CW) Y, that is to say a carbamoyl chloride when W represents O and Y represents -NRlR.2, a thiocar10 bamoyl chloride when W represents S and Y represents -NR ^ R ^, a chloroformate when W represents O and Y represents -OR ^, a chlorothionoformate when W represents S and Y represents -OR ^, a chlorothiolformate when W represents O and Y represents -SR ^ or a chlorodithioformate when W represents S and Y represents -SR ^;
• in the case where R0 represents the hydrogen atom and W represents O, reaction with phosgene, diphosgene or triphosgene to form the isocyanate and then treatment with HY;
• in the case where R0 represents the hydrogen atom and W represents S, reaction with thiophosgene to form the isothiocyanate and then treatment with HY;
• in the case where Y represents -NHR *, reaction with R'N = (CW);
· In the case where W represents S, Y represents -SR ^ and R0 is different from the hydrogen atom, reaction with carbon disulphide and R ^ X, X representing a halogen atom or any other leaving group.
In addition, compounds of general formula (I) can be converted into other compounds of general formula (I) by derivatization of R0 or radicals.
R ^ or R ^ or R ^; or by acylation, cyanation or alkylation when W represents O and RO or Rl or R ^ or R ^ represent the hydrogen atom;
- 142812633
In the case where RP is different from the hydrogen atom, compounds of general formula (II) can be prepared from compounds of general formula (III) according to Scheme 2 below:
Diagram 2
<img file="FR2812633A1_D0004.tif" />
<img file="FR2812633A1_D0005.tif" />
The following reaction conditions can be used to carry out the conversion:
• in the case where rP represents an alkyl radical, formylation or acylation with an anhydride followed by reduction with borane dimethylsulphide;
• in the case where RP represents a cyano radical, cyanation with cyanogen chloride or bromide;
• in the case where R® represents an acyl radical, acylation with an acyl halide.
The compounds of general formula (III) can be prepared by reduction of the nitro radical of the compounds of formula (IV) according to Scheme 3. The preferred reaction conditions comprise a reaction with hydrazine hydrate in ethanol catalyzed by palladium or platinum;
Diagram 3
<img file="FR2812633A1_D0006.tif" />
-152812633
The compounds of formula (Ilia), that is to say the compounds of general formula (III) in which A represents a direct bond, can be prepared according to Scheme 4, in which X<sup>v</sup> represents a leaving group:
<img file="FR2812633A1_D0007.tif" />
The compounds of formula (IIIb), that is to say the compounds of general formula (III) in which R ^ represents a halogen atom, can be prepared according to Scheme 5, in which χΤ represents a halogen atom.
When X4 is bromine the preferred reaction conditions include stirring with bromine in a suitable solvent.
Diagram 5
<img file="FR2812633A1_D0008.tif" />
<img file="FR2812633A1_D0009.tif" />
(Mb)
The compounds of formula (Mc), that is to say the compounds of general formula (III) in which A represents NHC (= O) -; the compounds of formula (III), that is to say the compounds of formula (III) in which A represents a direct bond and
R ^ represents the optionally substituted phthalimido radical, in which the line
- 162812633 curve connecting positions 3 and 4 of the phthalimido radical represents the optionally substituted carbocyclic chain; and the compounds of formula (III), that is to say the compounds of general formula (III) in which A represents a direct bond and R.6 represents the pyrrolyl radical, optionally substituted in positions 2 and 5 by one or more radicals R which may be the same or different; can be prepared from compounds of formula (V) according to the methodology presented in Scheme 6. For some compounds of formula (V), the protection / deprotection of the amino group in the ortho position of the R ^ group may be required to improve the results. yields.
Diagram 6
<img file="FR2812633A1_D0010.tif" />
The compounds of formula (IVa), that is to say the compounds of general formula (IV) in which A represents a radical A<sup>z</sup>, can be prepared by reacting the compounds of formula (VI) with the compounds of formula (VII) according to Scheme 7. A<sup>z</sup> represents a radical which, in compound (VI), forms an anion under basic conditions. AT<sup>z</sup> alternatively represents a primary or secondary basic nitrogen atom. X<sup>z</sup> represents a leaving group, preferably a halogen atom. When A<sup>z</sup> represents the oxygen atom, conditions of
Preferred reactions include treatment of (VI) with sodium hydride followed by addition of (VII). When A<sup>z</sup> represents the sulfur atom, the preferred reaction conditions comprise the reaction of (VI) with (VII) in the presence of a tertiary amine base such as ethyldiisopropylamine. When A<sup>z</sup> represents s CHR<sup>7</sup>-, the preferred reaction conditions comprise the treatment of (VI) with potassium ZerZ-butoxide in dimethylformamide at low temperature. When A<sup>z</sup> represents a basic nitrogen atom, no base is required.
Diagram 7
R<sup>6</sup>-AT<sup>z</sup>-H (VI)
<img file="FR2812633A1_D0011.tif" />
The compounds of formula (IVb), that is to say the compounds of general formula (IV) in which A represents a radical A<sup>w</sup>, can be prepared by reacting compounds of formula (VIII) with compounds of formula (IX) according to
Figure 8. A<sup>w</sup> represents a radical which, in a compound (VIII), forms an anion under basic conditions. X<sup>w</sup> represents a leaving group, preferably a halogen atom. Preferred basic conditions include the reaction of (VIII) with potassium carbonate carbonate or sodium hydride followed by the addition of (IX).
Figure 8
<img file="FR2812633A1_D0012.tif" />
M
1) Base
2) R<sup>6</sup>-X<sup>w</sup> (IX)
<img file="FR2812633A1_D0013.tif" />
NO<sub>2</sub>
M)
R<sup>4</sup> (VIII) (IVb)
<img file="FR2812633A1_D0014.tif" />
,5·
- 182812633
The compounds of formula (IVc), that is to say the compounds of general formula (IV) in which A represents O, can be prepared by reaction of compounds of formula (X) with boronic acids of formula (XI) according to Scheme 9. Preferred reaction conditions include reaction with copper acetate and triethylamine.
Figure 9
<img file="FR2812633A1_D0015.tif" />
The compounds of formula (IVd), that is to say the compounds of formula (IV) Io in which A represents a direct bond can be prepared according to the Scheme from compounds of formula (XII) in which X<sup>z</sup> represents a leaving group, preferably a halogen atom.
Figure 10
<img file="FR2812633A1_D0016.tif" />
<img file="FR2812633A1_D0017.tif" />
The compounds of formula (IV) in which A represents a direct bond and R.6 represents a heterocyclyl radical can be prepared using numerous methods known to those skilled in the art (for example see “Comprehensive Heterocyclic Chemistry”, Flights 1-7, AR Katritzky and CW Rees). By way of example, the routes of access to compounds of formula (IV) containing a l, 2,4-oxadiazol-3-yl radical [compound (IVe)] and a l, 3,4-oxadiazol-2 radical -yl [compound (IVf)] are shown in Schemes 11 and 12.
- 192812633
Figure 11
<img file="FR2812633A1_D0018.tif" />
<img file="FR2812633A1_D0019.tif" />
<img file="FR2812633A1_D0020.tif" />
Figure 12
<img file="FR2812633A1_D0021.tif" />
The compounds of formula (IIIf), that is to say the compounds of general formula (III) in which A represents -CHR<sup>7</sup>- with R<sup>7</sup> representing a hydroxy or alkoxy radical, can be prepared from compounds of formula (IIIg) according to the methodology described in Scheme 13, where R represents an optionally substituted alkyl radical or the hydrogen atom, and where R<sup>6</sup> represents an optionally substituted carbo- or heterocyclic radical which can form an anion under basic conditions.
Similarly, the reaction sequence described in Scheme 13 can be carried out on the compounds of formula (IIIf) where the amine function is replaced by a precursor of said function, for example the radical -NO2 or the radical - N (CW) Ro.
-202812633
<img file="FR2812633A1_D0022.tif" />
- R<sup>6</sup>-H, base
- possibly alkylation
<img file="FR2812633A1_D0023.tif" />
Alternatively , using chemistries similar to those described above, the compounds of general formula (I) can be prepared by introducing R<sup>6</sup> after the formation of the entity -NRq (CW) Y.
Other methods for accessing the compounds of formula (1) as well as their intermediates and starting compounds will appear obvious to those skilled in the art, such as those described for example in Brown, BR The Organic Chemistry of Aliphatic Nitrogen Compounds (Oxford Science Publications, 1994) and Patai, S. The chemistry of cyanates and their thio derivatives (John Wiley & Sons, 1977).
In addition, the compounds according to the invention can be prepared using the well known techniques of combinatorial chemistry.
The invention is illustrated by the following Examples but should not be understood as limited by them. The structures of the new, isolated compounds were confirmed by NMR and / or other appropriate analyzes. Proton NMR spectra (^ H NMR) were recorded in deuterochloroform and chemical shifts (δ) are given in parts per million relative to tetramethylsilane.
Example 1
7 / - (4-1 [3- (1.1 -dimethvlethyl ') phenvl1oxv) -2,5-dimethvlphénvl) - ^ - ethvl- / Vmethylthiourea (Compound 27)
To a solution of 1 - {[3- (1,1 -dimethylethyl) phenyl] oxy} -4-isothiocyanato-2,5dimethylbenzene (1.9 g) in tetrahydrofuran (6 mL) at 0 ° C is added dropwise to drop of methylmethylamine (450 mg). The reaction mixture obtained is stirred at
-21 room temperature for 1 h then concentrated and triturated with heptane. The title product is obtained in the form of a bench precipitate.
Preparation of Starting Products 1-chloro-2,5-dimethyl-4-nitrobenzene
To a mixture cooled to 10 ° C of 2-chloro-1,4-xylene (1.4 g), acetic acid (17 mL) and 98% sulfuric acid (1 mL) is added dropwise a sulfonitric mixture at 0 ° C composed of sulfuric acid (3.8 mL) and nitric acid (1 mL).
The reaction medium is poured into a water / ice mixture and then filtered. The yellow precipitate is recrystallized from petroleum ether to give the title compound.
1 - ((3- (1,1 -dimethylethvDphenylloxy 1 -2,5-dimethyl-4-nitrobenzene
To a solution of 1-chloro-2,5-dimethyl-4-nitrobenzene (9.5 g) in dimethylformamide (60 mL) under an inert atmosphere is added 3 - / - butyl phenol (7.5 g) and potassium carbonate (6.9 g). The reaction mixture obtained is heated at reflux for 5 h, then partitioned in a water / diisopropyl ether mixture. The organic phase is washed with a basic aqueous solution, then with water at pH.
7. Drying over magnesium sulphate then adding carbon black followed by filtration over Celite makes it possible to obtain, after concentration, the title product.
4-173- (1,1 -dimethylethyl) phenvHoxy} -2,5-dimethylaniline
To a mixture of 1 - ((3- (1, 1-dimethylethyl) phenyl] oxy} -2,5-dimethyl-4-nitrobenzene (8.65 g) and 5% palladium on charcoal (100 mg) in "-Propanol (60 mL) heated to 90 ° C is added dropwise hydrazine hydrate (4.3 mL). The reaction mixture is maintained at 90 ° C for 2 h then filtered through Celite. Concentration allows get the title compound.
1 - ((3- (1,1 -diméthvléthvl) phenylloxy) -4-isothiocyanato-2,5-dimethylbenzene
To a two-phase mixture at room temperature of 4 - ((3- (1,1dimethylethyl) phenyl) oxy) -2,5-dimethylaniline (1.35 g) in toluene (6 mL) and sodium bicarbonate (840 mg ) in water (6 mL) is added thiophosgene (0.38 mL). The reaction mixture obtained is stirred for 2 h then decanted. The aqueous phase is extracted with toluene, then the reunified organic phases are washed with water, dried (magnesium sulfate) and then concentrated to give the title product.
-222812633
The procedure described for the synthesis of N - (4 - ((3- (1,1 -dimethylethyl) phenyl) oxy) -2,5-dimethylphenyl) -jV-ethyl-jY-methylthiourea has been generalized to other amines and transposed at other temperature and solvent conditions, in particular acetonitrile, diethyl ether and dimethylformamide. This procedure was also used for the synthesis of thiosemicarbazides and thiohydroxylureas.
In the case of 1- (4 - {[3- (1,1-dimethylethyl) phenyl] oxy} -2,5dimethylphenyl) -l, 3-dihydro-2H-imidazole-2-thione (Compound 16 ), cyclic lathiourea was obtained by reacting, according to the procedure described above, aminoacetaldehyde dimethyl acetal with 4 - {[3- (1,1-dimethylethyl) phenyl] oxy} 2.5-dimethylaniline.
The procedure described for preparing 4- {[3- (1,1 -dimethylethyl) phenyl] oxy} 2.5-dimethylaniline was also used to prepare the following anilines: 4 - [(3-chlorophenyl) oxy] -2,5-dimethylaniline, 4 - {[4-chloro-3- (trifluoromethyl) phenyl] -oxy} -2,5-dimethylaniline, 4- ([4 -fluoro-3- (trifluoromethyl) phenyl] oxy} -2,5dimethylaniline, 2,5-dimethyl-4 - {[3- (trifluoromethyl) phenyl] oxy} aniline, 4 - [(4ethylphenyl) oxy] -2 , 5-dimethylaniline, 4 - [(4-chlorophenyl) oxy] -2,5-dimethylaniline and 4 - {[3- (1,1-dimethylethyl) phenyl] oxy} -2- (trifluoromethyl) aniline.
Other anilines used as intermediates in the synthesis of exemplified products were synthesized according to the following methods.
Preparation of 4- (5- (1, 1-dimethylethyl) -l, 3,4-oxadiazol-2-yl) -2-methylaniline
To a solution at room temperature of methyl 3-methyl-4-nitrobenzoate (25 g) in methanol (300 mL) is added hydrazine hydrate (6.7 mL). The reaction mixture is heated for 15 minutes at reflux and then cooled. The filtered and dried precipitate corresponds to 3-methyl-4-nitrobenzohydrazide.
To a mixture consisting of 3-methyl-4-nitrobenzohydrazide (3.9 g), triethylamine (3 mL) and 2,2-dimethylpropanoic acid chloride (2.6 mL) in dichloromethane (120 mL) and stirred for 2 h is added water. After drying, evaporation and tritutation of the organic phase in petroleum ether, 7V- (2,2dimethylpropanoyl) -3-methyl-4-nitrobenzohydrazide is obtained in the form of a precipitate.
<img file="FR2812633A1_D0024.tif" />
-23 2812633
To a suspension of jV '- (2,2-dimethylpropanoyl) -3-methyl-4nitrobenzohydrazide (5.1 g) in toluene (200 mL) is added phosphorus pentoxide (10 g). After heating at reflux for 2 h, the reaction mixture is poured into ice-cold water and extracted with diethyl ether. The organic phases are combined, dried over magnesium sulfate, evaporated and purified by chromatography on silica (eluent diethyl ether / petroleum ether: 2: 1) to give the
2- (1,1 -dimethylethyl) -5- (3-methyl-4-nitrophenyl) -1,3,4-oxadiazole.
A mixture of 2- (1,1-dimethylethyl) -5- (3-methyl-4-nitrophenyl) -1,3,4oxadiazole (1.6 g), of FeCl<sub>3</sub>.6H<sub>2</sub>O (5 g) and zinc powder (4 g) in a dimethylformamide / water mixture (1: 1, 25 mL) is heated at 100 ° C for 30 minutes then filtered through celite. After dilution with a saturated aqueous solution of sodium carbonate, the reaction mixture is extracted with diethyl ether. Drying over magnesium sulphate and evaporation of the organic phase makes it possible to obtain the title aniline.
Preparation of 2,5-dimethvl-4-IY3-phenvl-l, 2,4-thiadiazol-5-vl) oxy] phenylamine
To a suspension of sodium hydride (60% dispersion in mineral oil,
3g) in anhydrous dimethylformamide (300 mL) is added at room temperature 4-amino-2,5-dimethylphenol (10.5 g). The reaction mixture is stirred for 30 minutes then 5-bromo-3-phenyl-1,2,4-thiadiazole (18 g) prepared according to Chem. Ber. 1961, 94, 2043 is added slowly. After stirring for 15 h, the reaction mixture is diluted in ice-cold water and then extracted with diethyl ether. Drying over magnesium sulfate followed by concentration of the combined organic phases allows the title compound to be obtained.
Preparation of 4- [3.4-dihvdro-2 (7 //) - isoquinoléinvl] -2,5-dimethylaniline
A mixture of 1-chloro-2,5-dimethyl-4-nitrobenzene (1.65 g) and 1,2,3,4tetrahydroisoquinoline (5 mL) in TV-methylpyrolidine (5 mL) is stirred at 140 ° C for 15h. Dilution in water followed by extraction with diethyl ether and chromatography on silica (eluent petroleum ether / diethyl ether: 1: 1) of the dried and evaporated organic phase gives the 2- (2, 5-dimethyl-4nitrophenyl) -1, 2,3,4-tetrahydro-isoquinoline.
2- (2,5-dimethyl-4-nitrophenyl) -1, 2,3,4-tetrahydro-isoquinoline is reduced according to the methods exemplified above to give the title aniline.
-242812633
Preparation of 4- (1-Benzothiophen-2-yl) -2,5-dimethvlanilin
A mixture of 1-bromo-2,5-dimethyl-4-nitrobenzene (3.6 g), (1-benzothien2-yl) boronic acid (3.6 g), palladium tetrakistriphenylphosphine (0.4 g) , aqueous solution (2M) of sodium carbonate (17 mL) in ethanol (36 mL) and toluene (100 mL) is stirred at reflux for 18 h. Partial evaporation followed by extraction with ethyl acetate, drying of the organic phase followed by further evaporation makes it possible to obtain 2- (2,5-dimethyl-4-nitrophenyl) -lbenzothiophene .
2- (2,5-Dimethyl-4-nitrophenyl) -1-benzothiophene is reduced according to the methods described above to give the title aniline.
Example 2
3- 14- (1-Benzothien-2-yl) -2,5-dimethylphenyll-2-thioxo-1,3-thiazolidin-4-one (Compound 3)
A solution of 2- (4-isothiocyanato-2,5-dimethylphenyl) -l-benzothiophene (0.22 g) and ethyl sulfenylacetate (0.09 g) in diethyl ether (2 mL) is stirred for 18 h at room temperature . The reaction medium is evaporated and then triturated in petroleum ether to give the title compound.
Example 3
N- (4- {r4-chloro-3- (trifluoromethyl) phenylloxvl-2,5-dimethylphenyl) -JV, / V'-diethylTV'-methylurea (Compound 116)
To a solution of 4 - {[4-chloro-3- (trifluoromethyl) phenyl] oxy} -2,5-dimethylaniline (3 g) in anhydrous ethyl acetate (50 mL) is added at 60 ° C. under argon, a spatula of activated carbon then diphosgene (2.07 g). The reaction mixture obtained is heated at 60 ° C. for 1 h then stirred at room temperature for 15 h. Filtration through Celite followed by evaporation and recovery in petroleum ether (50 mL) to which is added jV-ethylmethylamine (1.12 g) makes it possible to obtain after evaporation the jV '- ( 4 - {[4-chloro-3- (trifluoromethyl) phenyl] oxy} -2,5dimethylphenyl) -7V-ethyl- / V-methylurea. To a solution of the latter compound (380 mg) in tetrahydrofuran (2 mL) is added a suspension of 60% sodium hydride in mineral oil (46 mg) followed by ethyl iodide (300 mg). The
-252812633 reaction mixture is stirred at 50 ° C for 2 h then diluted in water and extracted with diethyl ether. Drying the organic phase over magnesium sulfate followed by evaporation gives the title compound.
The procedure described for the synthesis of N '- (4 - {[4-chloro-3- (trifluoromethyl) phenyl] oxy} -2,5-dimethylphenyl) -A<sup>r</sup>-ethyl -? / - methylurea has been generalized to other amines and transposed to other solvents, notably acetonitrile, diethyl ether and dimethylformamide. Similar procedures have been used for the synthesis of hydroxylureas, semicarbazides and carbamates.
The following examples (Table 1) illustrate, in a nonlimiting manner, some compounds according to the present invention and which were synthesized from the preceding procedures.
Table 1
<img file="FR2812633A1_D0025.tif" />
NB: Me signifies methyl, Et signifies ethyl, Pr signifies propyl, Bu signifies butyl, Ph signifies phenyl, n signifies linear, i signifies iso, t signifies tertio.
For the sake of clarity, the indices have not been shown; thus CH2 means CH2, CO2 means CO2, etc.
-262812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 1</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>NEtMe</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
<td> 2</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NMe2</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
<td> 3</td><td>Me</td><td>Me</td><td>s</td><td>single link with Y</td><td>-S FO Ά</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
<td> 4</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>N-Morpholino</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
<td> 5</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHCH2Ph</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
<td> 6</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>OEt</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 7</td><td>Me</td><td>Me</td><td>s</td><td>single link with Y</td><td>-S FO H</td><td> 0</td><td>3-trifluoromethylphenyl</td>
<td> 8</td><td>H</td><td>Me</td><td>s</td><td>H</td><td>NHMe</td><td>bond straightforward</td><td>N <</td>
<td> 9</td><td>H</td><td>Me</td><td>s</td><td>H</td><td>NH-cyclopropyl</td><td>bond straightforward</td><td>N <</td>
<td> 10</td><td>H</td><td>Me</td><td>s</td><td>H</td><td>NHCH2Ph</td><td>bond straightforward</td><td>Ν '' N γγ<sup>χ</sup></td>
<td> 11</td><td>H</td><td>Me</td><td>s</td><td>H</td><td>N-Morpholino</td><td>bond straightforward</td><td>ch<sub>3</sub></td>
<td> 12</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>OMe</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
-27 2812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 13</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>NHMe</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
<td> 14</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>Butyl ot</td><td>bond straightforward</td><td>2-benzothiophenyl</td>
<td> 15</td><td>H</td><td>Me</td><td>s</td><td>H</td><td>NHMe</td><td>bond straightforward</td><td>N v- q 'γ V = N 0¾</td>
<td> 16</td><td>Me</td><td>Me</td><td>s</td><td>single link with Y</td><td>H - N Fü \ = J</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 17</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>£ / o</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 18</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>Ό</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 19</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHEt</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 20</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>N-Morpholino</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 21</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NH / Pr</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 22</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHnPr</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 23</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHcyclopropyl</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 24</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NMe2</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 25</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>h I</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 26</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td> ? <sup>H</sup></td><td> 0</td><td>3-tBu-phenyl</td>
<td> 27</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NEtMe</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 28</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NnBuMe</td><td> 0</td><td>3-tBu-phenyl</td>
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 29</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>Y</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 30</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>NHMe</td><td>o</td><td>4-Et-phenyl</td>
<td> 31</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td></td><td> 0</td><td>3-tBu-phenyl</td>
<td> 32</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td></td><td> 0</td><td>3-tBu-phenyl</td>
<td> 33</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>O-ί butyl</td><td> 0</td><td>3-tBu-phenyl</td>
<td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>
<td> 34</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>H</td><td> 0</td><td>3-tBu-phenyl</td>
<td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>
<td> 35</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td></td><td>o</td><td>3-tBu-phenyl</td>
<td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>
<td> 36</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>* trYj</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 37</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHMe</td><td>o</td><td>4-chlorophenyl</td>
<td> 38</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NH / Pr</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 39</td><td>Me</td><td>Me</td><td> 0</td><td>Me</td><td>Qt butyl</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 40</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td> ^3</td><td> 0</td><td>3-tBu-phenyl</td>
-292812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 41</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>H -VN '' 'CH, ÎH,</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 42</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHMe</td><td> 0</td><td></td>
<td> 43</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NEtMe</td><td> 0</td><td>3-trifluoromethylphenyl</td>
<td> 44</td><td>Me</td><td>Me</td><td>s</td><td>single link with Y</td><td>-N A3</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 45</td><td>Me</td><td>Me</td><td>s</td><td>single link with Y</td><td>-S FO H</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 46</td><td>Me</td><td>Me</td><td>s</td><td>single link with Y</td><td>-S RO K</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 47</td><td>H</td><td>CF3</td><td>s</td><td>H</td><td>NEtMe</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 48</td><td>Me</td><td>Me</td><td>s</td><td>single link with Y</td><td>RO 0 0</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 49</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>OMe</td><td> 0</td><td>3-trifluoromethylphenyl</td>
<td> 50</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHMe</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 51</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHMe</td><td>bond straightforward</td><td></td>
III
-302812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 52</td><td>Me</td><td>Me</td><td>S</td><td>single link with Y</td><td>RD M</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 53</td><td>Me</td><td>Me</td><td>S</td><td>single link with Y</td><td>RD M o</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 54</td><td>Me</td><td>Me</td><td>S</td><td>single link with Y</td><td>FO '<sub>NOT</sub>^ V I</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 55</td><td>Me</td><td>Me</td><td>S</td><td>single link with Y</td><td>FO 'n ^ M J</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 56</td><td>Me</td><td>Me</td><td>S</td><td>single link with Y</td><td>1> H</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 57</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NHPh</td><td> 0</td><td>3-trifluoromethylphenyl</td>
<td> 58</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>NHPh</td><td> 0</td><td>3-trifluoromethylphenyl</td>
<td> 59</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>HN</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 60</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>N-Morpholino</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 61</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NEtMe</td><td> 0</td><td>3-tBu-phenyi</td>
-31 2812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 62</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td> 0</td><td> 0</td><td></td>
<td> 63</td><td>Me</td><td>Me</td><td> 0</td><td>single link with Y</td><td>H - N RD H</td><td> 0</td><td>b</td>
<td> 64</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHPh</td><td> 0</td><td>3-tBu-phenyl</td>
<td> 65</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NEtMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 66</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>> Τ<sup>Νχ</sup>ΝΗ<sub>2</sub></td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 67</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>HI , n 1 a VXÇ-</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 68</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 69</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>* O</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 70</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>aa) H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
-322812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 71</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 72</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>0 HU</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 73</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>αλΧ) HH</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 74</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>aX H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 75</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 76</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>0 N / A H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 77</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>-'Ά</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 78</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>"I oX</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
-33 2812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 79</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>Ά</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 80</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>ύ</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 81</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>ΛνΧΧ H</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 82</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>0 h II</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 83</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>aAjO HH</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 84</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>AV H</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 85</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 86</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>AÂ H</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 87</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>H I</td><td> .0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
-342812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 88</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>H H</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 89</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NHEt</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 90</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NH / 'Pr</td><td> 0</td><td>4-chloro-3-trifluoronnethylphenyl</td>
<td> 91</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NHcyclopropyl</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 92</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td> ,0</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 93</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 94</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NHPh</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 95</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NHCH2Ph</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 96</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 97</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 98</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>N-Morpholino</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 99</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td> ’<sup>S</sup>O</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 100</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>ΐί</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 101</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>cf Λ5</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
-35 2812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 102</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td>O</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 103</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td></td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 104</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td>O</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 105</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>NMeiBu</td><td>O</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 106</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>'O</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 107</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>OMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 108</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>OEt</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 109</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>Oi-Pr</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 110</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>OCH2Ph</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 111</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>H Λ '</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 112</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 113</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 114</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td></td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 115</td><td>Me</td><td>Me</td><td> 0</td><td>H</td><td>AY</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 116</td><td>Me</td><td>Me</td><td> 0</td><td>And</td><td>NEtMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 117</td><td>Me</td><td>Me</td><td> 0</td><td>Benzyl</td><td>NEtMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
-362812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 118</td><td>Me</td><td>Me</td><td> 0</td><td>Me</td><td>NEtMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 119</td><td>Me</td><td>Me</td><td> 0</td><td>3- propar gyi</td><td>NEtMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 120</td><td>Me</td><td>Me</td><td> 0</td><td>3-allyl</td><td>NEtMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 121</td><td>Me</td><td>Me</td><td> 0</td><td>(alpha- methyl) benzyl</td><td>NEtMe</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 122</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>\ O /</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 123</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>N-thiazolidinyl</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 124</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NMe / Pr</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 125</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NEt2</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 126</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHCH2Ph</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 127</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td></td><td> 0</td><td>3-fbutylphenyl</td>
<td> 128</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>H</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 129</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>I</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 130</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>Uk</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 131</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>Ό</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 132</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>N-Morpholino</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 133</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NEt2</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 134</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHCH2Ph</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 135</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>O</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 136</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHcyclopropyl</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
-372812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 137</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>O.</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 138</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 139</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 140</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>'O</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 141</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>N-Morpholino</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 142</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NEt2</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 143</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHCH2Ph</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 144</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>O</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 145</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHcyclopropyl</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 146</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>'O.</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 147</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NH / Pr</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 148</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>H</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 149</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NEtMe</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 150</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>λ "<sub>NOT</sub>o H</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 151</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td> U</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
-382812633
<td>Cmpsé</td><td>R5</td><td>R4</td><td>W</td><td>RO</td><td>Y</td><td>AT</td><td>R6</td>
<td> 152</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>H</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 153</td><td>Me</td><td>Me</td><td>S</td><td>H</td><td>NHfBu</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 154</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHfBu</td><td> 0</td><td>4-fl uoro-3-trifl uoromethy I pheny I</td>
<td> 155</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHfBu</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 156</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NMe2</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 157</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NMe2</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 158</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NHEt</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 159</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NH2</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 160</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>NH2</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 161</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td> U</td><td> 0</td><td>3-fbutylphenyl</td>
<td> 162</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td> U</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 163</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td> U</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 164</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td></td><td> 0</td><td>3-fbutylphenyl</td>
<td> 165</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td></td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 166</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>H</td><td> 0</td><td>4-chloro-3-trifluoromethylphenyl</td>
<td> 167</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>* υ</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
<td> 168</td><td>Me</td><td>Me</td><td>s</td><td>H</td><td>jO H</td><td> 0</td><td>4-fluoro-3-trifluoromethylphenyl</td>
-392812633
The analytical characteristics of the compounds of Table 1 are described in the following table.
Table 2
NB: the column (M + 1) represents the (molecular peak + 1) as determined experimentally by the API + mass spectrometry technique
<td>Cmpsé</td><td>mp (° C)</td><td>NMR (CDCI3)</td><td>(M + l)</td>
<td> 1</td><td> 135</td><td></td><td></td>
<td> 2</td><td> 183</td><td></td><td></td>
<td> 3</td><td></td><td></td><td> 370</td>
<td> 4</td><td> 177</td><td></td><td></td>
<td> 5</td><td> 93</td><td></td><td></td>
<td> 6</td><td></td><td></td><td> 342</td>
<td> 7</td><td></td><td></td><td> 398</td>
<td> 8</td><td> 201</td><td></td><td></td>
<td> 9</td><td> 156</td><td></td><td></td>
<td> 10</td><td> 133</td><td></td><td></td>
<td> 11</td><td> 167</td><td></td><td></td>
<td> 12</td><td> 157</td><td></td><td></td>
<td> 13</td><td></td><td></td><td> 327</td>
<td> 14</td><td> 133</td><td></td><td></td>
<td> 15</td><td> 186</td><td></td><td></td>
<td> 16</td><td></td><td>1.30 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>); 2.30 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 17</td><td></td><td>1.30 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.20 (s, 3H, ArCH<sub>3</sub>); 3.35 (s, 3H, OCH<sub>3</sub>); 4.05 (m, 2H, CH2NH); 5.30 (bs, 1H, NH); 5.45 (t, 1H, NCH (OCH<sub>3</sub>) CH<sub>2</sub>)</td><td></td>
<td> 18</td><td> 125</td><td></td><td></td>
<td> 19</td><td> 104</td><td></td><td></td>
<td> 20</td><td> 146</td><td></td><td></td>
<td> 21</td><td> 147</td><td></td><td></td>
<td> 22</td><td> 108</td><td></td><td></td>
<td> 23</td><td> 131</td><td></td><td></td>
<td> 24</td><td> 136</td><td></td><td></td>
-402812633
<td>Cmpsé</td><td>mp (° C)</td><td>NMR (CDCI3)</td><td>(M + l)</td>
<td> 25</td><td> 174</td><td></td><td></td>
<td> 26</td><td> 139</td><td></td><td></td>
<td> 27</td><td> 125</td><td></td><td></td>
<td> 28</td><td> 70</td><td></td><td></td>
<td> 29</td><td> 123</td><td></td><td></td>
<td> 30</td><td> 141</td><td></td><td></td>
<td> 31</td><td> 131</td><td></td><td></td>
<td> 32</td><td> 182</td><td></td><td></td>
<td> 33</td><td> 96</td><td></td><td></td>
<td> 34</td><td> 115</td><td></td><td></td>
<td> 35</td><td> 96</td><td></td><td></td>
<td> 36</td><td></td><td>1.15 (s, 9H, ArC (CH<sub>3</sub>)<sub>3</sub>); 2.15 (s, 3H, Ar (CH<sub>3</sub>)); 2.20 (s, 3H, Ar (CH<sub>3</sub>))</td><td></td>
<td> 37</td><td></td><td>2.17 (s, 3H, ArCH<sub>3</sub>); 2.20 (s, 3H, ArCH<sub>3</sub>); 3.13 (s, 6H, N (CH<sub>3</sub>)<sub>2</sub>)</td><td></td>
<td> 38</td><td></td><td>1.10 (d, 6H, CH (CH<sub>3</sub>)<sub>2</sub>); 1.30 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.20 (s, 3H, ArCH<sub>3</sub>); 4.00 (m, 1H, CH (CH<sub>3</sub>)<sub>2</sub>); 4.45 (d, 1H, CONH); 5.95 (s, 1H, ArNH)</td><td></td>
<td> 39</td><td></td><td></td><td> 384</td>
<td> 40</td><td> 147</td><td></td><td></td>
<td> 41</td><td> 88</td><td></td><td></td>
<td> 42</td><td> 191</td><td></td><td></td>
<td> 43</td><td> 122</td><td></td><td></td>
<td> 44</td><td></td><td>1.30 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>); 2.25 (s, 3H, ArCH<sub>3</sub>); 3.40 (s, 3H, NCH<sub>3</sub>); 4.25 (s, 2H, COCH<sub>2</sub>NOT)</td><td></td>
<td> 45</td><td></td><td>1.30 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>); 1.95 (s, 3H, ArCH<sub>3</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 4.20 (s, 2H, COCH<sub>2</sub>S)</td><td></td>
<td> 46</td><td></td><td>1.30 (s, 9H, (CH<sub>3</sub>)<sub>3</sub>); 1.80 (t, 3H, COCH (CH<sub>3</sub>) S); 1.95 (s, 3H, ArCH<sub>3</sub>); 2.30 (s, 3H, ArCH<sub>3</sub>); 4.40 (m, 1H, COCH (CH<sub>3</sub>) S)</td><td></td>
<td> 47</td><td> 63</td><td></td><td></td>
<td> 48</td><td> 134</td><td></td><td></td>
<td> 49</td><td> 89</td><td></td><td></td>
<td> 50</td><td> 136</td><td></td><td></td>
<td> 51</td><td> 164</td><td></td><td></td>
<td> 52</td><td> 122</td><td></td><td></td>
-41 2812633
<td>Cmpsé</td><td>mp (° C)</td><td>NMR (CDCI3)</td><td>(M + l)</td>
<td> 53</td><td></td><td>1.25 (s, 9H, C (CH<sub>3</sub>)<sub>3</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.20 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 54</td><td></td><td>1.20 (t, 3H, CH<sub>2</sub>CH<sub>3</sub>); 1.25 (s, 9H, C (CH<sub>3</sub>)<sub>3</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.20 (s, 3H, ArCH<sub>3</sub>); 2.75 (s, 3H, NCH<sub>3</sub>); 3.90 (m, 2H, NCH<sub>2</sub>); 4.3 (m, 4H, NCH<sub>2</sub>NOT)</td><td></td>
<td> 55</td><td></td><td>1.15 (m, 6H, 2CH<sub>2</sub>CH<sub>3</sub>); 1.20 (s, 9H, C (CH<sub>3</sub>)<sub>3</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.20 (s, 3H, ArCH<sub>3</sub>); 2.95 (m, 2H, CH<sub>2</sub>CH<sub>3</sub>); 3.9 (m, 2H, NCH<sub>2</sub>CH<sub>3</sub>); 4.4 (m, 4H, 2NCH<sub>2</sub>NOT)</td><td></td>
<td> 56</td><td></td><td>1.1 (t, 3H, CH<sub>2</sub>CH<sub>3</sub>); 1.25 (s, 9H, C (CH<sub>3</sub>)<sub>3</sub>); 2.10 (s, 3H, ArCH<sub>3</sub>); 2.20 (s, 3H, ArCH<sub>3</sub>); 3.8 (q, 2H, NCH<sub>2</sub>)</td><td></td>
<td> 57</td><td></td><td></td><td> 401</td>
<td> 58</td><td></td><td></td><td> 417</td>
<td> 59</td><td></td><td></td><td> 711</td>
<td> 60</td><td></td><td></td><td> 383</td>
<td> 61</td><td></td><td></td><td> 355</td>
<td> 62</td><td></td><td></td><td> 427</td>
<td> 63</td><td></td><td></td><td> 381</td>
<td> 64</td><td></td><td></td><td> 405</td>
<td> 65</td><td></td><td>3.44 (q, 2H, NCH<sub>2</sub>); 3.03 (s, 3H, NCH<sub>3</sub>); 2.19 (s, 3H, ArCH<sub>3</sub>); 2.12 (s, 3H, ArCH<sub>3</sub>); 1.22 (t, 3H, NCH<sub>2</sub>CH<sub>3</sub>)</td><td></td>
<td> 66</td><td></td><td>3.88 (s, 2H, NNH<sub>2</sub>); 3.24 (s, 3H, NCH<sub>3</sub>); 2.19 (s, 3H, ArCH<sub>3</sub>); 2.12 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 67</td><td></td><td>8.25 (s, 2H, CONH<sub>2</sub>); 2.22 (s, 6H, ArCH<sub>3</sub>); 2.07 (s, 6H, ArCH<sub>3</sub>)</td><td></td>
<td> 68</td><td></td><td>2.05 (s, 3H, ArCH<sub>3</sub>); 2.16 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 69</td><td></td><td>2.79 (M, 4H, NCH<sub>2</sub>); 2.17 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 70</td><td></td><td>2.10 (s, 3H, ArCH<sub>3</sub>); 2.04 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 71</td><td></td><td>2.14 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 72</td><td></td><td>2.07 (s, 3H, ArCH<sub>3</sub>); 2.03 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 73</td><td></td><td>2.16 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 74</td><td></td><td>3.60 (s, 3H, OCH<sub>3</sub>); 2.14 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 75</td><td></td><td>2.14 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 76</td><td></td><td>2.14 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>); 1.86 (s, 3H, COCH<sub>3</sub>)</td><td></td>
<td> 77</td><td></td><td>2.15 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 78</td><td></td><td>2.17 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 79</td><td></td><td>3.04 (m, 4H, NCH<sub>2</sub>); 2.22 (s, 3H, ArCH<sub>3</sub>); 2.17 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 80</td><td></td><td>2.22 (s, 3H, ArCH<sub>3</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 1.21 (d, 6H, NCH (CH<sub>3</sub>))</td><td></td>
-422812633
<td>Cmpsé</td><td>mp (° C)</td><td>NMR (CDCI3)</td><td>(M + l)</td>
<td> 81</td><td></td><td>2.13 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 82</td><td></td><td>2.06 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 83</td><td></td><td>2.16 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 84</td><td></td><td>2.60 (s, 3H, OCH<sub>3</sub>); 2.13 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 85</td><td></td><td>2.16 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 86</td><td></td><td>2.13 (s, 3H, ArCH<sub>3</sub>); 2.06 (s, 3H, ArCH<sub>3</sub>); 1.86 (s, 3H, COCH<sub>3</sub>)</td><td></td>
<td> 87</td><td></td><td>2.64 (s, 6H, NCH<sub>3</sub>); 2.21 (s, 3H, ArCH<sub>3</sub>); 2.16 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 88</td><td></td><td>3.24 (s, 3H, NCH<sub>3</sub>); 2.19 (s, 3H, ArCH<sub>3</sub>); 2.13 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 89</td><td></td><td>3.11 (q, 2H, NCH2CH<sub>3</sub>); 2.14 (s, 3H, ArCH<sub>3</sub>); 2.04 (s, 3H, ArCH<sub>3</sub>); 1.07 (t, 3H, NCH<sub>2</sub>CH<sub>3</sub>)</td><td></td>
<td> 90</td><td></td><td>3.75 (m, 1H, NCH (CH<sub>3</sub>)<sub>2</sub>); 2.13 (s, 3H, ArCH<sub>3</sub>); 2.04 (s, 3H, ArCH<sub>3</sub>); 1.11 (d, 6H, NCH (CH<sub>3</sub>)2)</td><td></td>
<td> 91</td><td></td><td>2.55 (m, 1H, NHCH (CH<sub>2</sub>) 2); 2.14 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>); 0.65 (m, 2H, NCH (CH<sub>2</sub>)<sub>2</sub>); 0.42 (m, 2H, NCH (CH<sub>2</sub>)<sub>2</sub>)</td><td></td>
<td> 92</td><td></td><td>3.42 (m, 4H, NCH<sub>2</sub>); 2.13 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 93</td><td></td><td>3.40 (t, 2H, OCH<sub>2</sub>); 3.30 (s, 3H, OCH<sub>3</sub>); 3.27 (t, 2H, NCH<sub>2</sub>); 2.14 (s, 3H, ArCH<sub>3</sub>); 2.04 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 94</td><td></td><td>2.22 (s, 3H, ArCH<sub>3</sub>); 2.08 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 95</td><td></td><td>4.45 (d, 2H, NHCH<sub>2</sub>Ph); 2.16 (s, 3H, ArCH<sub>3</sub>); 2.05 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 96</td><td></td><td>4.82 (q, 1H, NCH); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.02 (s, 3H, ArCH<sub>3</sub>); 1.40 (d, 3H, NCH (CH<sub>3</sub>)</td><td></td>
<td> 97</td><td></td><td>3.93 (t, 4H, NCH<sub>2</sub>); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.0 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 98</td><td></td><td>3.62 (m, 4H, NCH<sub>2</sub>); 3.42 (m, 4H, CH2O); 2.13 (s, 3H, ArCH<sub>3</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 99</td><td></td><td>2.29 (s, 3H, ArCH<sub>3</sub>); 2.10 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 100</td><td></td><td>2.23 (s, 3H, ArCH<sub>3</sub>); 2.08 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 101</td><td></td><td>3.89 (s, 3H, OCH<sub>3</sub>); 2.22 (s, 3H, ArCH<sub>3</sub>); 2.08 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 102</td><td></td><td>2.22 (s, 3H, ArCH<sub>3</sub>); 2.09 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 103</td><td></td><td>9.36 (s, 1H, CCHN); 2.22 (s, 3H, ArCH<sub>3</sub>); 2.09 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 104</td><td></td><td>3.95 (m, 2H, CH<sub>2</sub>CF<sub>3</sub>); 2.14 (s, 3H, ArCH<sub>3</sub>); 2.04 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 105</td><td></td><td>2.92 (s, 3H, NCH<sub>3</sub>); 2.09 (s, 3H, ArCH<sub>3</sub>); 2.04 (s, 3H, ArCH<sub>3</sub>); 1.34 (s, 9H, NCCH<sub>3</sub>)</td><td></td>
<td> 106</td><td></td><td>2.32 (s, 3H, ArCH<sub>3</sub>); 2.11 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 107</td><td></td><td>3.67 (s, 3H, OCH<sub>3</sub>); 2.16 (s, 3H, ArCH<sub>3</sub>); 2.08 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
-43 2812633
<td>Cmpsé</td><td>mp (° C)</td><td>NMR (CDC1<sub>3</sub>)</td><td>(M + l)</td>
<td> 108</td><td></td><td>4.12 (q, 2H, OCH<sub>2</sub>); 2.16 (s, 3H, ArCH<sub>3</sub>); 2.08 (s, 3H, ArCH<sub>3</sub>); 1.25 (t, 3H, OCH2CH<sub>3</sub>)</td><td></td>
<td> 109</td><td></td><td>4.87 (m, 1H, OCH); 2.15 (s, 3H, ArCH<sub>3</sub>); 2.08 (s, 3H, ArCH<sub>3</sub>); 1.26 (t, 6H, OCH (CH<sub>3</sub>)<sub>3</sub>)</td><td></td>
<td> 110</td><td></td><td>5.14 (s, 2H, OCH<sub>2</sub>Ph); 2.14 (s, 3H, ArCH<sub>3</sub>); 2.06 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 111</td><td></td><td></td><td> 389</td>
<td> 112</td><td></td><td></td><td> 465</td>
<td> 113</td><td></td><td></td><td> 403</td>
<td> 114</td><td></td><td></td><td> 415</td>
<td> 115</td><td></td><td></td><td> 431</td>
<td> 116</td><td></td><td>3.40 (q, 2H, ArNCH<sub>2</sub>); 3.04 (q, 2HCONCH<sub>2</sub>); 2.46 (s, 3H, NCH<sub>3</sub>); 2.13 (s, 3H, ArCH<sub>3</sub>); 2.08 (s, 3H, ArCH<sub>3</sub>); 1.05 (t, 3H, ArNCH<sub>2</sub>CH<sub>3</sub>); 0.77 (t, 3H, CONCH<sub>2</sub>CH<sub>3</sub>)</td><td> 429</td>
<td> 117</td><td></td><td>4.56 (s, 2H, ArCH<sub>2</sub>NOT) ; 3.06 (q, 2H, NCH<sub>2</sub>); 2.49 (s, 3H, NCH<sub>3</sub>); 1.99 (s, 3H, ArCH<sub>3</sub>); 1.93 (s, 3H, ArCH<sub>3</sub>); 0.73 (t, 3H, NCH<sub>2</sub>CH<sub>3</sub>)</td><td></td>
<td> 118</td><td></td><td>3.05 (q, 2H, NCH2CH<sub>3</sub>); 2.90 (s, 3H, ArNCH<sub>3</sub>); 2.46 (s, 3H, EtNCH<sub>3</sub>); 2.13 (s, 3H, ArCH<sub>3</sub>); 2.06 (s, 3H, ArCH<sub>3</sub>); 0.76 (t, 3H, NCH<sub>2</sub>CH<sub>3</sub>)</td><td></td>
<td> 119</td><td></td><td>4.18 (s, 2H, CH<sub>2</sub>NOT) ; 3.02 (q, 2H, NCH<sub>2</sub>); 2.50 (s, 3H, NCH<sub>3</sub>); 2.19 (s, 3H, ArCH<sub>3</sub>); 2.11 (s, 3H, ArCH<sub>3</sub>); 1.00 (t, 3H, NCH<sub>2</sub>CH<sub>3</sub>)</td><td></td>
<td> 120</td><td></td><td>3.94 (d, 2H, CH<sub>2</sub>CHCH<sub>2</sub>); 3.04 (q, 2H, NCH<sub>2</sub>CH<sub>3</sub>); 2.47 (s, 3H, NCH<sub>3</sub>); 2.10 (s, 3H, ArCH3); 2.05 (s, 3H, Ar € H<sub>3</sub>); 0.76 (t, 3H, NCH<sub>2</sub>CH<sub>3</sub>)</td><td></td>
<td> 121</td><td></td><td>5.30 (q, 1H, NCH); 4.03 (q, 2H, NCH<sub>2</sub>CH<sub>3</sub>); 2.47 (s, 3H, NCH<sub>3</sub>); 2.01 (s, 3H, ArCH<sub>3</sub>); 1.82 (s, 3H, ArCH<sub>3</sub>); 1.40 (d, 3H, NCH<sub>2</sub>CH<sub>3</sub>); 0.63 (t, 3H, NCH<sub>2</sub>CH<sub>3</sub>)</td><td></td>
<td> 122</td><td></td><td></td><td> 373</td>
<td> 123</td><td></td><td>4.83 (m, 3H, NCH<sub>3</sub>S); 3.97 (m, 2H, NCH<sub>2</sub>); 3.18 (m, 2H, SCH<sub>2</sub>); 2.22 (s, 3H, ArCH<sub>3</sub>); 2.17 (s, 3H, ArCH<sub>3</sub>); 1.31 (s, 9H, C (CH<sub>3</sub>)<sub>3</sub>)</td><td></td>
<td> 124</td><td></td><td>5.37 (m, 1H, NCH); 3.00 (s, 3H, NCH<sub>3</sub>); 2.09 (s, 3H, ArCH<sub>3</sub>); 2.06 (s, 3H, ArCH<sub>3</sub>); 1.11 (d, 6H, NCH (CH<sub>3</sub>)<sub>2</sub>)</td><td></td>
<td> 125</td><td></td><td></td><td> 386</td>
<td> 126</td><td></td><td>4.74 (d, 2H, NCH<sub>2</sub>Ph); 2.07 (s, 3H, ArCH<sub>3</sub>); 1.80 (s, 3H, ArCH<sub>3</sub>); 1.25 (s, 9H, CCH<sub>3</sub>)</td><td></td>
<td> 127</td><td></td><td></td><td> 384</td>
<td> 128</td><td></td><td></td><td> 388</td>
<td> 129</td><td></td><td></td><td> 436</td>
-442812633
<td>Cmpsé</td><td>mp (° C)</td><td>NMR (CDCI3)</td><td>(M + l)</td>
<td> 130</td><td></td><td></td><td> 413</td>
<td> 131</td><td></td><td></td><td> 444</td>
<td> 132</td><td></td><td></td><td> 446</td>
<td> 133</td><td></td><td></td><td> 432</td>
<td> 134</td><td></td><td></td><td> 466</td>
<td> 135</td><td></td><td></td><td> 430</td>
<td> 136</td><td></td><td></td><td> 416</td>
<td> 137</td><td></td><td></td><td> 459</td>
<td> 138</td><td></td><td></td><td> 434</td>
<td> 139</td><td></td><td></td><td> 482</td>
<td> 140</td><td></td><td></td><td> 427</td>
<td> 141</td><td></td><td></td><td> 429</td>
<td> 142</td><td></td><td></td><td> 415</td>
<td> 143</td><td></td><td></td><td> 449</td>
<td> 144</td><td></td><td></td><td> 413</td>
<td> 145</td><td></td><td></td><td> 399</td>
<td> 146</td><td></td><td></td><td> 442</td>
<td> 147</td><td></td><td></td><td> 401</td>
<td> 148</td><td></td><td></td><td> 417</td>
<td> 149</td><td></td><td></td><td> 401</td>
<td> 150</td><td></td><td></td><td> 465</td>
<td> 151</td><td></td><td></td><td> 464</td>
<td> 152</td><td></td><td></td><td> 401</td>
<td> 153</td><td></td><td></td><td> 432</td>
<td> 154</td><td></td><td></td><td> 415</td>
<td> 155</td><td></td><td></td><td> 386</td>
<td> 156</td><td></td><td></td><td> 404</td>
<td> 157</td><td></td><td></td><td> 387</td>
<td> 158</td><td></td><td></td><td> 404</td>
<td> 159</td><td></td><td></td><td> 329</td>
<td> 160</td><td></td><td></td><td> 376</td>
<td> 161</td><td></td><td></td><td> 421</td>
-45 2812633
<td>Cmpsé</td><td>mp (° C)</td><td>NMR (CDCI3)</td><td>(M + l)</td>
<td> 162</td><td></td><td></td><td> 467</td>
<td> 163</td><td></td><td></td><td> 450</td>
<td> 164</td><td></td><td></td><td> 370</td>
<td> 165</td><td></td><td></td><td> 416</td>
<td> 166</td><td></td><td></td><td> 452</td>
<td> 167</td><td></td><td>4.05 (t, 4H, NCH<sub>2</sub>); 2.07 (s, 3H, ArCH<sub>3</sub>); 1.80 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
<td> 168</td><td></td><td>2.07 (s, 3H, ArCH<sub>3</sub>); 1.80 (s, 3H, ArCH<sub>3</sub>)</td><td></td>
Examples Tests
The compounds were evaluated for their activity against one or more of the following fungal diseases:
Phytophthora infestons: tomato downy mildew Erysiphe graminis f. sp. Tritici: powdery mildew of wheat Pyricularia oryzae: blast of rice Leptosphaeria nodorum: septoria of wheat, variety nodorum îo Mycosphaerella graminicola: septoria of wheat, variety tritici Puccinia recondita: brown rust of cereals Pyrenophora teres: blight of wheat
Aqueous solutions or dispersions of the compounds at the desired concentration, including one or more wetting agents, are applied by spraying or dipping the base of the stem of the test plants, as the case may be. After a given time, the plants or parts of the plants are inoculated with the appropriate test pathogens, and stored under controlled environmental conditions suitable for maintaining plant growth and disease development. After an appropriate time, the degree of infection of the infected part of the plant is visually estimated. At a concentration of 500 ppm (w / v) or less, the following compounds show a control of at least 65% efficacy against the specified fungal diseases compared to an untreated control.
Phytophthora infestons 44, 45
-462812633
Erysiphe graminis f. sp. Tritici
1, 17, 18, 19, 20, 21, 22, 23, 24, 27, 28, 33, 42, 43, 45, 52, 53, 54, 55, 83, 84, 124
Pyricularia oryzae 35
Leptosphaeria nodorum
18, 27, 45, 124
Puccinia recondita
124, 127, 131, 140, 149, 157, 167
Pyrenophora teres
77,93,95, 113, 118, 119, 124, 128, 132, 140, 144, 145,149, 150, 157, 164, 165
Contents5
27 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| DE3102590A1 | Cites | Germany | X | Search report | 1-6 |
| US4005223A | Cites | United States of America | X | Search report | 1-3 |
| US4328248A | Cites | United States of America | XA | Search report | 1-3 |
| US4540578A | Cites | United States of America | X | Search report | 1-3 |
| US4914098A | Cites | United States of America | X | Search report | 1-3 |
| US5066667A | Cites | United States of America | X | Search report | 1-3 |
| US6083970A | Cites | United States of America | X | Search report | 1-6 |
12 members in 9 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 0010305 | France | A | |
| FR20000010305 | – | – | – |
Members12
| Document | Office | Kind | |
|---|---|---|---|
| EP1178039A1 | European Patent Office (EPO) | A1 | |
| FR2812633A1This record | France | A1 | |
| JP2002114751A | Japan | A | |
| US2003008884A1 | United States of America | A1 | |
| US6696487B2 | United States of America | B2 | |
| EP1178039B1 | European Patent Office (EPO) | B1 | |
| DK1178039T3 | Denmark | T3 | |
| AT359265T | Austria | T | |
| DE60127772D1 | Germany | D1 | |
| PT1178039E | Portugal | E | |
| ES2284605T3 | Spain | T3 | |
| DE60127772T2 | Germany | T2 |
Numbers
- Publication
- 2812633
- Publication, DOCDB
- 2812633
- Publication, EPODOC
- FR2812633
- Application
- 10305
- Application, DOCDB
- 0010305
- Application, EPODOC
- FR20000010305
Titles2
- French
- DERIVES DE PHENYL(THIO)UREES ET PHENYL(THIO)CARBAMATES FONGICIDES
- English
- PHENYL (THIO) UREA AND PHENYL (THIO) CARBAMATE FUNGICIDE DERIVATIVES
Classification
- CPC, 33
- C07D209/48
- A01N43/64
- A01N43/78
- A01N43/88
- A01N47/20
- A01N47/30
- A01N47/32
- A01N47/34
- A01N47/38
- C07C271/28
- C07C275/36
- C07C275/64
- C07C281/06
- C07C311/49
- C07C333/24
- C07C335/18
- C07C335/40
- C07C337/06
- C07D207/09
- C07C2601/02
- C07D213/61
- C07D213/75
- C07D213/77
- C07D235/14
- C07D239/42
- C07D271/06
- C07D271/10
- C07D285/08
- C07D295/21
- C07D295/32
- C07D307/20
- C07D307/68
- C07D317/58
- IPC, 46
- C07D295 20
- A01N43 50
- A01N43 64
- A01N43 78
- A01N43 86
- A01N43 88
- A01N47 20
- A01N47 30
- A01N47 32
- A01N47 34
- A01N47 36
- A01N47 38
- C07C271 28
- C07C275 36
- C07C275 64
- C07C281 06
- C07C311 49
- C07C333 08
- C07C333 24
- C07C335 18
- C07C335 40
- C07C337 06
- C07D207 09
- C07D209 48
- C07D213 61
- C07D213 75
- C07D213 76
- C07D213 77
- C07D217 04
- C07D235 10
- C07D235 14
- C07D239 42
- C07D265 30
- C07D271 06
- C07D271 10
- C07D277 04
- C07D277 36
- C07D285 08
- C07D295 21
- C07D295 22
- C07D295 28
- C07D307 20
- C07D307 33
- C07D307 68
- C07D317 58
- C07D333 58